Overview

Cancer of the Pancreas Screening Study (CAPS 3)

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find the best and most sensitive screening modality (CT, MRI, EUS)for very small pre-cancerous pancreatic lesions and to treat these small lesions before they turn into cancer. Another purpose of this study is to search for common markers on DNA that would increase the chance of someone developing pancreatic cancer, and locate proteins in pancreatic juice that indicate tumor development.
Details
Lead Sponsor:
Johns Hopkins University
Collaborators:
Lustgarten Foundation
National Cancer Institute (NCI)
Treatments:
Pancrelipase
Secretin